ByrneJVSohnMJMolyneuxAJ: Five-year experience in using coil embolization for rupturet intracranial aneurysms: outcomes and incidence of late rebleeding. J Neurosurg90 (4): 656–663, 1999.
2.
MishraVSkeieB: A comparison of actual registered costs and costs derived from diagnosis-related groups (DRGs) for patients undergoing heart transplantation, lung transplantation, and thoracotomy for other lung diseases. Transpl Int14 (6): 361–369, 2001.
3.
MolyneuxAJKerrR: International Subarachnoid Aneurysm Trial. J Neurosurg91: 352–353, 1999.
4.
NomeTBakkeSJNakstadPH: MR angiography in rthe follow-up of coiled cerebral aneurysms treated with guglielmi detachable coils. Acta Radiol43: 10–14, 2002.
5.
OgilvyCSCarterBS: A proposed comprehensive grading system to predict outcome for surgical management of intracranial aneurysms. Neurosurgery42 (5): 959–970, 1998.
6.
PedersenHKBakkeSJ: CTA in patients with subarachnoid haemorrhage. Acta Radiologica42 (1): 43–49, 2001.
7.
ReedSDBloughDK: Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. Neurology57: 305–314, 2001.
8.
RoosYBWEMDijkgraafMGW: Direct costs of modern treatment of aneurysmal subarachnoid haemorrhage in the first year after diagnosis. Stroke33: 1595–1599, 2002.
9.
SamuelsenRJ: Politicians' priorities requested by hospital executives [Sykehusledere ber politikerne prioritere]. Norwegian, Aftenposten 1997.
10.
YundtKDDaceyRGDiringerMN: Hospital resource utilization in the treatment of cerebral aneurysms. J Neurosurg85: 403–409, 1996.
